BackAmphastar Pharmaceuticals Overview
Amphastar Pharmaceuticals Inc

Amphastar Pharmaceuticals Target Price

Where could AMPH trade next? Consensus target price: $23.

Get informed when a big investor buys or sells

+ Follow

Share Price

$29.37

Average Target Price

$23.0021.7% downside

1 analysts in the last 4 months

High: $23 | Low: $23

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-18Barclays$2321.7% downsideOpen
2026-06-03Barclays$2031.9% downsideOpen
2026-05-14Wells FargoBenjamin Burnett$1935.3% downsideOpen
2026-05-11Piper Sandler$2128.5% downsideOpen
2026-04-20JefferiesDennis Ding$2225.1% downsideOpen
2025-12-08Barclays$302.1% upsideOpen
2025-03-21Piper SandlerDavid Amsellem$329% upsideOpen
2024-08-08Piper SandlerDavid Amsellem$66124.7% upsideOpen
2024-05-23Piper SandlerDavid Amsellem$71141.7% upsideOpen
2022-03-12Piper SandlerDavid Amsellem$3519.2% upsideOpen

Amphastar Pharmaceuticals (AMPH) FAQ

As of the most recent data, AMPH shows a target price of $23. Scroll down for historical charts and peer comparison views.

If Amphastar Pharmaceuticals moved to the average analyst target of $23, shares would be roughly 21.7% lower than $29.37. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Amphastar Pharmaceuticals's earnings trajectory.

Besides this target price page, Stockcircle has Amphastar Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $23) with ownership activity and broader fundamentals.

Amphastar Pharmaceuticals's target price is $23; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.